DRUG NAME THERAPE INDICA ADVERSE REACTION CONTRAINDI NURSING

UTIC TION CATION CONSIDER

ACTIONS ATION
Generic Name: Drug is CV: bradycardia, hy Contraindicat Instruct
acetylcholine used potension, flushing. ed in patient to
chloride during EENT: corneal patients report
ophthal edema, clouding, hypersensitiv breathing
mic decompensation. e to drug or difficulties
surgery Respiratory: breathi its immediatel
Brand to ng difficulties. components. y.
Name:Miochol cause Skin: diaphoresis.
-E rapid,
comple
te
Dosage, Route and miosis.
Frequency:
Adults and
children: 0.5 to
2 ml of 1%
solution instilled
gently in
anterior
chamber of eye.

Classification:
Pharmacologic
classification: ch
olinergic agonist
Therapeutic
classification: m
iotic

Pregnancy risk:
category NR
DRUG NAME THERAPEU INDICATIO ADVERSE CONTRAINDICAT NURSING
TIC N REACTION ION CONSIDERATI
ACTIONS ON
Generic Acute CNS: headache, Contraindicated Instruct
Name: postoperati malaise. in patients patient to take
bethanechol ve and CV: flushing, hypersensitive to oral form on
chloride postpartum hypotension, drug or its an empty
nonobstruc reflex components. Also stomach and
tive tachycardia. contraindicated in at regular
Brand (functional) EENT: patients with intervals.
Name: urine lacrimation, uncertain • Inform
retention, miosis. strength or patient that
neurogenic GI: abdominal integrity of the drug is usually
Dosage, atony of cramps, bladder wall, effective
Route and urinary diarrhea, mechanical within 30 to 90
Frequency: bladder excessive obstructions of minutes after
Adults: 10 with salivation, the GI or urinary oral
to 50 mg retention. nausea, tract, administration.
P.O. b.i.d., belching, hyperthyroidism,
t.i.d, or borborygmi. peptic ulceration,
q.i.d. When GU: urinary latent or active
used for urgency. bronchial asthma,
urine
Hepatic: liver pronounced
retention,
some
dysfunction. bradycardia or
patients Respiratory: hypotension,
may bronchoconstric vasomotor
require 50 tion, increased instability, cardiac
to 100 mg bronchial or coronary artery
P.O. per secretions. disease, seizure
dose. Use Skin: disorder,
such doses diaphoresis. Parkinson’s
with
disease, spastic GI
extreme
disturbances,
caution.
Adjust acute
dosage to inflammatory
meet lesions of the GI
individual tract, peritonitis,
requiremen or marked
ts. vagotonia. Also
contraindicated
when increased
muscular activity
Classification of GI or urinary
: tract is harmful.
Pharmacolo
gic
classificatio
n:
cholinergic
agonist
Therapeutic
classificatio
n: urinary
tract and
GI tract
stimulant

Pregnancy
risk:
 2
DRUG NAME THERAPEUT INDICATIO ADVERSE CONTRAINDICATI NURSING
IC ACTIONS N REACTION ON CONSIDERATI
ON
Generic Name: Adjunct to CV: Contraindicated in Explain all
pancuronium anesthesia tachycardia, patients events and
bromide to induce increased hypersensitive to procedures to
skeletal blood bromides, in those patient because
muscle pressure. with tachycardia, he can still
Brand relaxation, GI: excessive and in those for hear.
Name: facilitate salivation. whom even a • Reassure
intubation Musculoskelet minor increase in patient that
and al: residual heart rate is breathing will
Dosage, Route ventilation muscle undesirable. return to
and Frequency: , and weakness. normal once
Adults and weaken Respiratory: therapy is
children older muscle prolonged, discontinued.
than age 1 contractio dose-related
month: Initially, ns in respiratory
0.04 to 0.1 induced insufficiency
mg/kg I.V.; then seizures. or apnea.
0.01 mg/kg q Skin: transient
25 to 60 rashes.
minutes if Other: allergic
needed. or
idiosyncratic
hypersensitivi
ty reactions.
Classification:
Pharmacologi
c
classification
:
nondepolarizi
ng
neuromuscul
ar blocker
Therapeutic
classification
: skeletal
muscle
relaxant

Pregnancy risk:
category C
 DRUG THERA INDIC ADVERSE REACTION CONTRAI NURSING
NAME PEUTI ATIO NDICATIO CONSIDE
C N N RATION
ACTIO
NS
2
Generic To CNS: Hypersens Use
Name: reduc headache,restlessness,ataxia,disorientation,ha itive to cautiously
Atropine e llucinations,insomnia,dizziness,agitation,conff nitrates in patients
Sulfate respir usion and in with
atory CV: palpitations,bradycardia,tachycardia those with Down
tract EENT: photophobia,blurred early MI, syndrome
Brand secre vision,mydriasis,cycloplegia,increased severe because
Name: tions intraocular pressure anemia, they may
AtroPe relate GI: dry mouth thirst, increased be more
n d to constipation,nausea,vomiting intracrani sensitive
anest GU: urine retention,impotence. al to drug;
Dosage, hesia pressure,
Route angle- Many
and closure adverse
Frequen glaucoma, reaction
cy: orthostati (such as
c dry mouth
hypotesio and
n,allergy constipati
Classific to on) vary
ation: adhesive with the
(transder dose;
Antiarrh
mal), or
ythmias
hypersens Monitor
itivity to patients
nitrates. for
Pregnan
I.V. paradoxic
cy risk:
nitroglyce al initial
rin is bradycard
contraindi ia,especial
cated in ly those
patients receiving
hypersens small
itive to doses (0.4
I.V. form, to 0.6mg).
cardiac This
tamponad usually
e disappear
s within 2
minutes;

Watch for
tachycardi
a in
cardiac
patients
because it
may lead
to
ventricula
r
fibrillation
;
DRUG NAME THERAPEUTI INDICATION ADVERSE CONTRAINDICATIO NURSING
C ACTIONS REACTIO N CONSIDERATIO
N N
Generic Prevention of Contraindicated Assess
Name: and with allergy to
Salmeterol maintenance hypersensitivity to salmeterol
xinafoate therapy for salmeterol, acute ;pregnancy,
bronchospas asthma attack, acute asthma
m in select worsening or attack,
Brand patients with deteriorating worsening
Name: asthma, asthma (life- asthma,
chronic threatening), acute lactation
obstructive airway obstruction. -
Dosage, pulmonary - Ensure that drug
Route and disease, and Use cautiously with is not used to
Frequency: exercise- pregnancy, lactation treat acute
induced asthma or with
asthma worsening or
deteriorating
Classification:
DRUG NAME THERAPEUTI INDICATIO ADVERSE CONTRAINDICATIO asthma (risk of
NURSING
Beta2- C ACTIONS N REACTIO N death).
CONSIDERATIO
selective N - N
adrenergic Instruct in the
Generic
agonist proper use of
Name:
Antasthmat diskus.
ic -
Monitor use of
Brand
inhaler; use of
Name:
Pregnancy more than
risk: 4puffs/day may
worsen asthma;
Dosage,
obtain
Route and
evaluation by
Frequency:
physician.
-
Have patients
who experience
Classification: exercise-induce
dasthma use it
30–60 min
Pregnancy before activity.
risk: -
Arrange for
periodicevaluati
on of respiratory
DRUG NAME THERAPEUTI INDICATIO ADVERSE CONTRAINDICATIO NURSING
C ACTIONS N REACTIO N CONSIDERATIO
N N
Generic
Name:

Brand
Name:

Dosage,
Route and
Frequency:

Classification:

Pregnancy
risk:
DRUG NAME THERAPEUTI INDICATIO ADVERSE CONTRAINDICATIO NURSING
C ACTIONS N REACTIO N CONSIDERATIO
N N
Generic
Name:

Brand
Name:

Dosage,
Route and
Frequency:

Classification:

Pregnancy
risk: